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4 The Journal of Thoracic and CardiovaThe article in this issue of the Journal by the Canadian CABG Surgery QualityIndicator Consensus Panel entitled “The identification and development ofCanadian coronary artery bypass graft surgery quality indicators”1 brings to
the forefront an increasingly important issue for health care providers. As a financ-
ing crisis looms in the US health care system, both public and private purchasers are
demanding more transparency and performance data related to services provided.
This is grounded in the belief that improving quality will lead to cost savings, a point
clearly made in the Society of Thoracic Surgeons (STS) testimony before the House
Ways and Means Committee in March 2005.2 The Center for Medicare and
Medicaid Services (CMS) Director McClellan believes, as do others in the private
sector, that payments for health care services should be adjusted according to
quality. This has driven the need for the development of specialty-specific quality
and performance measures to be used for both quality improvement and account-
ability. Recognizing this need, the STS, under the leadership of Dr Peter Pairolero
in 2004 and Dr Sid Levitsky in 2005, have taken a leadership role in bringing the
use of the STS National Cardiac Database (STS NCD) and the STS as a professional
society to a position of national prominence. Through the National Quality Forum
(NQF) Consensus Development Process, a set of 21 performance measures for
cardiac surgery suitable for quality improvement and accountability have been
established, with 16 of these measures specified and derived from the STS NCD.
The complete description can be found in the NQF publication “National Voluntary
Consensus Standards for Cardiac Surgery.”3 The Canadian group has followed suit
with an independent project to mirror these efforts in the United States by the STS.
A careful comparison of these projects and a discussion of the implications for US
cardiac surgeons are imperative.
The Canadian CABG Survey Quality Indicator Consensus panel is well de-
scribed in their article, with the important point being that 75% of its members were
specialty specific, a topic touched on later. The inclusion of Dr Frederick Grover,
incoming president of the STS, with 2 decades of experience in measure develop-
ment initially at the Veterans Health Administration and subsequently with the STS
database, gave enormous credibility to this project as did the presence of Dr
O’Conner from the Northern New England Cardiovascular Disease Study Group
(NNE). The group used a Delphi Consensus process, which is, in essence, blinded
voting on the attributes of measures after thoughtful open discussion. The final result
included 18 measures covering the spectrum of structure, process, and outcomes, as
found in the Donabedian model of quality improvement. Specifically, the set
included 14 outcome measures (none risk adjusted), 3 process measures, and 1
structural measure (volume). Arguably, 2 of the 3 process variables (waiting time to
surgical intervention and completion of surgical intervention within a recommended
waiting time) represent measures of efficiency system capacity rather than processes
of care. Additionally, one of the outcome measures, intensive care unit (ICU) length
of stay, might also fall into the category of system capacity because transfer out of
the ICU might be influenced by lack of step-down or telemetry beds or floor nurse
shortages, for example, and might not reflect quality of care. To their credit, they
paired this measure with ICU readmission, which enables inappropriate early
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mance measure to be monitored by readmission rates. Un-
fortunately, this was not done with ventilation time, which
should have had reintubation rates as a paired measure.
Importantly, the level of analysis for all of the variables is
defined at the hospital level as it is in the NQF measure set,
a not insignificant issue. The weaknesses of the data set
include the lack of risk adjustment for all outcome variables,
the inclusion of only one true process variable, the lack of
homogeneity of data source (clinical or administrative is
equally acceptable for any measure), and the absence of any
recommendation for participation in a systematic database.
Each will be discussed in turn.
The reporting of raw outcomes data is a highly conten-
tious issue across medical specialties in the United States.
Adequate risk adjustment is considered the sine qua non for
outcomes reporting to accurately characterize results on the
basis of patient acuity and to prevent the unintended conse-
quence of avoidance of high-risk patients. The NQF project
actually considered several of the Canadian outcome measures
(eg, postoperative myocardial infarction and blood product
use) but rejected them because of the difficulty in defining
postoperative myocardial infarction and the complicating fac-
tor of widespread oral and intravenous antiplatelet agent use
in the United States, making it difficult to use these mea-
sures in the absence of risk adjustment. This issue has
weighed heavily in discussions at the NQF by many pro-
viders and has been a stumbling block in the development of
outcomes measures both in the outpatient and inpatient
setting. On the other hand, given the time-sensitive needs of
the marketplace for data, many believe there must be a
starting place for outcome measure reporting. All NQF-
endorsed consensus standard sets are meant to be dynamic,
and the need for periodic revision is clearly recognized.
Hopefully this will occur in the Canadian set. Therefore I
applaud the courage of the Canadian cardiac surgeons to
begin reporting unadjusted outcomes measures with the
presumption that adequate risk adjustment will follow.
Process measures, on the other hand, can be precisely
defined and specified and are not subject to risk adjustment.
They are ideal measures to include as performance mea-
sures if there is a defined link to quality improvement.
Exclusion criteria for process measures certainly exist, but
one can eliminate the need to create lengthy lists of exclu-
sionary criteria by setting the threshold for the measure not
at 100% but at a level based on aggregate national data. For
purposes of illustration, internal thoracic artery (ITA) use
has known contraindications for use during coronary artery
bypass grafting (eg, use in a prior operation, emergency
operation for cardiogenic shock, and poor sternal quality).
The Leapfrog group, in using this measure as one of their
monitors of quality, has approximately 20 exclusions for
use of the ITA. The accurate collection of these data is not
The Journal of Thoraonly difficult and lends itself to “gaming” but also repre-
sents a large data burden on providers. If every process
measure had as many exclusions and every specialty devel-
oped similar measures, the data burden on the system would
be enormous and likely impossible to accomplish. The STS,
under the leadership of Dr Fred Edwards, Chair STS NCD,
developed a simplified approach in its NQF measure set, as
described above, and currently is in the process of examin-
ing its aggregate national data to determine current percent-
age use for each of the process measures in the NQF set.
Most importantly, the use of administrative data for
in-hospital condition-specific care is fraught with error and
ambiguity. In the United States claims data are designed and
function well for billing purposes. Beyond that, they repre-
sent inaccurate pictures of care delivery at its best and danger-
ous markers of outcomes at its worst. Analyses by Mack and
colleagues4 and in the blended STS/CMS MedPAR database
of the Virginia Cardiac Surgery Initiative have documented
wide variations in the ability to accurately capture cardiac
surgery outcomes data by using administrative databases.
Underreporting of deaths, process measures, and procedural
volume is commonplace in the CMS database. When ex-
amining the CMS data for the state of Virginia and com-
paring it with the STS data, 9% of procedures were not
reported (discharge Diagnostic Related Groups [DRGs] of-
ten do not match procedures performed), mortality rates
were lower, and ITA use was underreported by as much as
50% in a single institution with a statewide average of 17%5.
Perhaps the administrative data in Canada are far better than
those in the United States, but nonetheless, the use of admin-
istrative data and the lack of an explicit single data source for
any one measure in the Canadian set are worrisome. Anal-
ysis of outcomes based on those sites submitting clinical
data for a given measure will be markedly different than
those using administrative data if the pattern of discrepancy
seen in the United States holds true in Canada. CMS clearly
recognizes this problem and in recent discussions has
agreed in principle to accept data from specialty databases
in its upcoming Physician Voluntary Reporting Program.
Finally, the STS leadership firmly believes that partici-
pation in a systematic clinical database is the foundation of
quality improvement. The accurate collection, reporting,
and analysis of these data with feedback loops to providers
are the essential ingredients for continuous quality improve-
ment. Best practices can be identified and processes of care
adapted to improve outcomes. It is only through this mech-
anism that system transformation can occur at the hospital-
physician level, ultimately leading to improved care across
all disciplines. Of note, this measure is included in the
NQF set.
A direct comparison between the NQF National Volun-
tary Consensus Standards for Cardiac Surgery and the Ca-
nadian CABG Surgery Quality Indicators requires a broader
cic and Cardiovascular Surgery ● Volume 131, Number 1 5
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open membership organization whose mission is to improve
health care through the endorsement of consensus-based
national standards for measurement and public reporting of
health care data that provide meaningful information about
whether care is safe, timely, beneficial, patient centered,
equitable, and efficient. The NQF was formed subsequent to
a recommendation of a Presidential advisory commission
and comports with the requirements of the National Tech-
nology Transfer and Advancement Act of 1995 (P.L. 104-
113) and Office of Management and Budget Circular A-119.
The importance of this lies in the fact that measures, when
vetted through the NQF’s formal consensus development
process, enjoy a special legal status, obligating federal agen-
cies to use the measures as specified if a measure is to be
adopted for use by these agencies. The NQF represents the
entire spectrum of health care delivery and is an organiza-
tion of organizations with now nearly 300 member organi-
zations. Members are divided into 4 councils: consumers,
purchasers, providers and health plans, and research and
quality improvement organizations. When a project is iden-
tified and funded, a call for nominations for the steering
committee is made. These nominations come from all sec-
tors of health care and not just the specialty involved. Once
seated, a call for measures appropriate to the project from
any member or nonmember occurs. This allows consumers,
purchasers, and all stakeholders to submit measures they
deem important. In the case of the Cardiac Surgery project,
a technical advisory panel (TAP) was created, chaired by Dr
T. Bruce Ferguson. The TAP deliberates and delivers sug-
gested measures to the steering committee. Through a series
of multiple face-to-face meetings and numerous conference
calls, an agreed upon set of measures is sent to the members
and then made open for public comment. Refinements are
made as necessary, and the measure set is then sent to all
NQF members for a vote. If approved by its councils, the
measure set is then sent to the NQF Board of Directors
(BOD) for final approval. The BOD membership is impres-
sive, with ranking members of 4 federal agencies (CMS,
Agency for Healthcare Research and Quality, Joint Com-
mission on Accreditation of Healthcare Organization, and
the National Institutes of Health) and the states (state health
officers and Medicaid), as well as major purchasers (Gen-
eral Motors and UPS), consumers (American Association of
Retired Persons and March of Dimes), and health care
experts.
The importance of this lengthy description is to show the
stark contrast between the Canadian consensus process and
that of the NQF. Specifically, the Canadian Consensus
Panel was comprised of 19 members, and as mentioned
earlier, at least 75% were specialty specific. This composi-
tion mirrored the TAP for the NQF cardiac surgery project
(70% specialty specific) but was quite different in compo-
6 The Journal of Thoracic and Cardiovascular Surgery ● Januarsition from the steering committee, where only 6 of 16
members were specialty specific, with the other members
representing federal agencies, as well as consumers, pur-
chasers, other providers, and health plans (complete list
available in the publication). As co-chair of this project, my
understanding of the needs of all of the stakeholders was
enormously increased and, at times, eye opening. The need
to have the measure set approved by 4 councils and their
members and the BOD was challenging, but the process lent
itself to the development of a credible set of measures for
our specialty with buy-in across the entire spectrum of
health care delivery, a daunting task in the absence of the
NQF Consensus Development Process. This should not
be taken as a criticism of the Canadian project, which
was done exceptionally well, but an illustration of the
diversity of the input during the NQF project. Because of
this diversity, one of the attributes of measures necessary
for inclusion in an NQF measure set is that they have
been in broad use and “field tested.” Therefore some of the
measures appearing in the Canadian set were considered but
eliminated on these grounds.
In direct comparison with the Canadian set, the NQF set
consists of 11 risk-adjusted outcomes measures (7 related to
CABG alone and 4 to valve surgery), 8 process measures
with links to quality improvement, and, as mentioned pre-
viously, database participation as one of its structural mea-
sures. The Canadian article does an excellent job of con-
trasting the 2 sets, noting a 50% overlap across all measures.
Most notable, though, is the fact that all 7 NQF outcomes
measures for CABG appear in the Canadian set, although
with some minor variation in definition specifications. How-
ever, none of these are risk adjusted. This begs the question
as to why the Canadian consensus panel did not or does not
merely adopt the risk-adjusted STS outcomes measures in
their measure set. Subscription to the STS NCD cannot be
used as an argument because all of these risk-adjusted
measures can be calculated on the STS Web site, a direct
result of the NQF cardiac surgery project. This would pro-
vide Canadian cardiac surgeons and their institutions the
comfort of knowing that their publicly reported perfor-
mance accurately depicts their patient acuity and is statis-
tically credible. It would also allow comparisons between
outcomes in the Canadian single-payer system to that of the
public-private system in the United States, not a small issue,
and certainly one that will attract an enormous amount of
attention by health care policy experts on both sides of the
border, especially as Canada expands its private health care
sector.
The Canadian set does include 2 extraordinarily impor-
tant long-term measures, those of 1-year repeat revascular-
ization by means of either percutaneous coronary intervention
or CABG. These are achievable because of the single-payer
system in Canada and the ability to use its administrative data
y 2006
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United States these data can only be obtained through the
acquisition of data from CMS and all private health plans,
which is doable but complicated at present. The issue was
discussed extensively during the NQF project and is high on
the radar screens of purchasers, as well as health plans. It is
widely recognized as a measure of effectiveness of therapy
and will begin to weigh heavily in the debate between
multivessel percutaneous coronary intervention versus
CABG, especially when costs are considered. As important
(or perhaps more so), this represents a battleground for our
specialty, and therefore the need for these types of data is
crucial. As you will note, this entire issue was made a
research recommendation in the final NQF publication, and
the STS NCD is currently in discussion with the Duke
Clinical Research Institute to develop a method to capture
these data.
The additional presence of 2 measures of efficiency in
the Canadian set is notable (waiting time to surgical inter-
vention and completion of surgical intervention within a
recommended waiting time) and represents system capacity,
and therefore these are not likely applicable in the United
States. However, measures of efficiency related to cost of
care delivery are believed to be sorely needed in the United
States, and both the NQF and Agency for Healthcare Re-
search and Quality are in the early phases of project devel-
opment to define the appropriate attributes of such mea-
sures. Purchasers and health plans are very intent on the
development of such measures and would welcome the
input of providers in doing so. It is clear that the health
maintenance organization cost-containment debacle through
restriction of services should not be repeated, and therefore
it is incumbent on us as a professional society to help
develop these measures with the clear proviso that they be
linked to quality. The STS has recently submitted a proposal
to Congress for funding of a project entitled “Quality Fo-
cused Cost Containment in Cardiac Surgery,” which will
address the development of measures of efficiency done in
a patient-centered, quality-guided, and scientifically credi-
ble manner.
Nothing that has been written to this point should have been
particularly surprising or contentious. The STS and others, like
the NNE, have been developing quality-performance mea-
sures for more than a decade, and their use is widely
adopted for internal use for continuous quality improve-
ment. What has not been embraced widely is the concept of
accountability, which for most in health care translates into
public reporting of data for use by consumers, purchasers,
and payers. Outside of states in which mandatory reporting
is already occurring (New York, Pennsylvania, California,
and Massachusetts to name a few), cardiac surgeons have
pushed back the public release of data. Perhaps more con-
troversial is the level of analysis at which those data are
The Journal of Thorareported (surgeon vs hospital) and the format in which those
data should/will be reported (specified measure data vs rating
vs ranking of providers). I include the word “will” here
because as you will soon hear—as I have heard from all
corners of health care and most policy makers—“this train
has left the station.” In the current health care financing
crisis, in which costs are increasing at multiples of inflation,
purchasers are demanding more data from health plans on
the quality of the health care for which they are paying. As
stated earlier, there is widespread belief that costs will track
quality. CMS and private payers are moving in the direction
of “value-based purchasing” in health care by the develop-
ment of programs that will pay for quality, more commonly
known as pay-for-performance programs. There are cur-
rently 2 bills in Congress, one in the House (HR. 3617) and
one in the Senate (S. 1356), that will link physician payment
to performance. CMS plans to institute a Pay for Reporting
program for physician reimbursement in January 2006.
How, when, and if data will be publicly reported are still to
be decided. If this program tracks that for the hospitals,
which is currently up and running, data will be on the CMS
Web site in 18 to 24 months. Where the data will come from
is fairly clear. The current design is for the data source to be
the CMS administrative claims database, a dangerous en-
terprise solution for specialty-specific in-hospital care, as
was previously discussed. The STS is currently in discus-
sion with CMS about the possibility of allowing clinical
databases, and in particular the STS database, to serve as a
source of data for its Physician Voluntary Reporting
Program.
One might argue that accountability does not necessarily
have to translate into public reporting. The STS and the
NNE have demonstrated significant quality improvement in
the absence of a public reporting system over the past
decade. This is a completely true and valid argument, but
this has not occurred in the remainder of medicine. Many
consumers and purchasers (eg, Leapfrog group) believe that
public reporting of performance data will be the only mo-
tivating factor for quality improvement. Sadly, they might
be right. As a result, cardiac surgeons will be drawn into the
whirlwind of the need for public reporting. Beyond that
argument lies the argument that publicly released data will
allow consumers to make health care provider choices,
payers to know that they are obtaining value in their health
care purchasing, and health plans to know that their network
providers are of acceptable quality. In fact, large corpora-
tions are providing incentives to their employees (eg, lower
copays) to choose providers on the basis of quality, which
argues even more strongly for the need for accurate public
data.
It appears that accountability public reporting is on the
horizon, and we must adjust to and embrace the concept.
More importantly, we must be at the table developing the
cic and Cardiovascular Surgery ● Volume 131, Number 1 7
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a credible fashion that will be widely adopted.
First and foremost, the level of analysis for cardiac
surgery must remain at the hospital level, as is found in the
NQF measure set. It is widely recognized that cardiac sur-
gery is a “team sport,” with outcomes affected by many
providers, as well as the system in which it is delivered.
CMS actually was a strong advocate of this position during
the NQF project and stated that the most significant oppor-
tunities for improvement and cost savings for CMS occur at
the system (hospital) level. Reporting might gravitate to the
group level at some point, but that discussion is still under-
way, with no thought to ever move to individual surgeon
reporting absent credible scientific data supporting it. We all
recognize that New York and Pennsylvania have surgeon-
specific reporting, but the benefits of this over hospital-level
or group reporting have yet to be demonstrated.
Second, participation in a clinical database with accurate
collecting and reporting of risk-adjusted data should provide
the level of comfort necessary to believe that these data
accurately reflect the performance of a hospital-group. Ab-
sent that, administrative data will be used, with the conse-
quent disbelief that we have all felt when seeing data
reported erroneously.
Third, we must be prepared to develop credible reporting
formats. Reporting of hard data for performance measures,
even when statistically adjusted, might prove too confusing
for consumers. Designating performance in a particular
measure as “less than expected, as expected, or greater than
expected” might be more understandable. Alternatively,
consumers might likely appreciate and benefit from a “roll-
up” measure that combines performance in all measures into
a single measure and rates providers on a graduated scale
(eg, 1 star through 3 stars). In fact, this last method might
work best for health plans as well, and Dr Fred Edwards
chairs a STS taskforce that is currently working with Well-
point/Anthem on determining the validity of such a meth-
odology. Certainly, we must attempt to avoid a system of
ranking that would profile providers from best to worst.
The message quite simply is that we as a professional
society must take the “fear of the unknown” and translate it
8 The Journal of Thoracic and Cardiovascular Surgery ● Januarinto “control of the known.” Unless we do it ourselves, I am
certain it will be done for us. The NQF Cardiac Surgery
project is a perfect example of this principle. Cardiac mea-
sures were being developed rapidly without our input. The
STS became the first specialty society to approach the NQF
with a project that would place us at the table. The results
speak for themselves. We now have 16 measures derived
from the STS NCD carrying special legal status that can be
used to measure quality in cardiac surgery and be used in
CMS and private sector pay-for-performance programs.
Our recognition that public reporting is here and that it is
a legitimate need of the health care system will again place
us in a privileged leadership position among health care
experts in this country. We must, however, be certain that it
is done properly, as we have done with quality improvement
for the past 15 years and performance measurement in the
recent NQF National Voluntary Consensus Standards for
Cardiac Surgery project. Quality indicators, performance
measurement, and accountability are clearly what consum-
ers, purchasers, and health plans want, need, and deserve.
This is the right thing to do, at the right time, and for the
right reasons.
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